2.83 -0.12 (-4.07%)
CYTK
Stock Details
Last Trade:2.83 Change:-0.12 (-4.07%) Prev Close:2.95 Open: 2.95 Days Range:2.78 – 2.95 52 Week Range: 1.39 - 5.80 Volume:214673 P/E: N/AEPS:-1.07
View AllRecent Alerts 07/04/09
Recent Alert on 06/02/09 at 7:50am
At ASCO, Cytokinetics (CYTK) Presents Data Relating to Ispinesib in Patients With Metastatic Breast Cancer
At ASCO, Cytokinetics (CYTK) Presents Data Relating to Ispinesib in Patients With Metastatic Breast Cancer
Cytokinetics, Incorporated (NASDAQ: CYTK) announced that a poster presentation summarizing interim data from the Phase I portion of a Phase I/II clinical trial evaluating ispinesib, a novel inhibitor of kinesin spindle protein (KSP), in patients... Read More
Recent Alert on 06/02/09 at 7:50am
At ASCO, Cytokinetics (CYTK) Presents Data Relating to Ispinesib in Patients With Metastatic Breast Cancer
At ASCO, Cytokinetics (CYTK) Presents Data Relating to Ispinesib in Patients With Metastatic Breast Cancer
Recent Alert on 06/01/09 at 4:07pm
Cytokinetics (CYTK) Announces Non-Clinical Data Relating to GSK-923295
Cytokinetics (CYTK) Announces Non-Clinical Data Relating to GSK-923295
Recent Alert on 06/01/09 at 4:07pm
Cytokinetics (CYTK) Announces Non-Clinical Data Relating to GSK-923295
Cytokinetics (CYTK) Announces Non-Clinical Data Relating to GSK-923295
Recent Alert on 05/27/09 at 9:45am
QVT Financial Boosts Stake in Cytokinetics (CYTK) to 8.44%, Profits From Yesterday's Big Surge
QVT Financial Boosts Stake in Cytokinetics (CYTK) to 8.44%, Profits From Yesterday's Big Surge
View AllRecent Press Releases
No Recent Press Releases Available